Results from a randomized phase III study comparing combined treatment with histamine dihydrochloride plus interleukin-2 versus interleukin-2 alone in patients with metastatic melanoma.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples